Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm. // Blood. – URL: https://www.sciencedirect.com/science/article/pii/S0006497126116553?dgcid=rss_sd_all
Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm. Blood. https://www.sciencedirect.com/science/article/pii/S0006497126116553?dgcid=rss_sd_all
“Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm.” Blood.
@article{article38271,
title = {Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm},
journal = {Blood},
url = {https://www.sciencedirect.com/science/article/pii/S0006497126116553?dgcid=rss_sd_all}
}